The preliminary agenda for the March meetings of the Regents is now available. The earlier schedule included March 19 as a third day, but the agenda indicates only the 17th and 18th.
Agenda: March 17-18, 2026, UC-San Francisco
==
Tuesday, March 17, 2026
--
10:30 am Investments Committee (open session- includes public comment session)
Public Comment Period (30 minutes)
Action: Approval of the Minutes of the Meeting of November 19, 2025
I1 Discussion: Investment Performance as of December 31, 2025 (Fiscal Year 2025–26)
--
1:00 pm Health Services Committee (open session)
Action: Approval of the Minutes of the Meeting of January 20, 2026
Information: Pivotal State Policy Challenges for 2026 and Beyond
--
Upon end of open session:
Health Services Committee (closed session)
Action: Approval of the Minutes of the Meeting of January 20, 2026
H3(X)2 Discussion: UC Health Litigation Update
--
2:40 pm Board (open session)
Remarks of the Chair of the Board
Remarks of the President of the University
Remarks of the Chair of the Academic Senate
Resolutions
B1 Discussion: UC Inspires: Innovation and Entrepreneurship Proof of Concept Funding Showcase
B2 Action: East Campus Medical Center Seismic Improvements and Renewal, San Diego Campus: Budget, Scope, External Financing and Design Following an Exemption Determination Pursuant to the California Environmental Quality Act
--
4:05 pm Board (closed session)
B3(X) Action: Acquisition of Health Care Assets, Los Angeles Campus
B4(X) Action: Proposed Medical Separation of a Faculty Member, Los Angeles Campus
==
Wednesday, March 18, 2026
--
8:30 am Board (open session - includes public comment session)
Public Comment Period (30 minutes)
Action: Approval of the Minutes of the Meetings of November 19, 2025 and January 20 and 21, 2026
Remarks from Student Associations
B5 Discussion: University of California Basic Needs Annual Report, 2024–25
--
9:45 am Board (closed session)
B6(X) Discussion: External Funding Litigation and Legal Issues
--
10:45 am Governance Committee (closed session)
Action: Approval of the Minutes of the Meeting of January 20, 2026
G1(X) Discussion: Collective Bargaining Matters
G2(X) Discussion: Market-Based Salary Adjustment for Deputy Laboratory Director for Operations and Chief Operating Officer, Lawrence Berkeley National Laboratory
--
Upon end of closed session:
Governance Committee (open session)
Action: Approval of the Minutes of the Meeting of January 20, 2026
G2 Action: Approval of Market-Based Salary Adjustment for Deputy Laboratory Director for Operations and Chief Operating Officer, Lawrence Berkeley National Laboratory as Discussed in Closed Session
--
11:45 am Finance and Capital Strategies Committee (closed session)
Action: Approval of the Minutes of the Meeting of September 17, 2025 and the Joint Meeting of the Health Services Committee and the Finance and Capital Strategies Committee of November 20, 2025
F1(X) Action: Canyon Springs Health Campus Site, Riverside Campus: Business Terms of Option to Ground Lease and Purchase
--
Upon end of closed session:
Finance and Capital Strategies Committee (open session)
Action: Approval of the Minutes of the Meeting of January 21, 2026
F2 Action: Consent Item: Big Shift Project #2, Davis Campus: Amendment of Budget, Scope, External Financing, Long Range Development Plan Amendment #3, and Design Following Consideration of an Addendum to the UC Davis Campus 2018 Long Range Development Plan Environmental Impact Report Pursuant to the California Environmental Quality Act
F3 Action: 5210 Pacific Concourse Drive Tenant Improvements, UCLA Health, Los Angeles Campus: Budget, Scope, External Financing, and Design Following Adoption of a Mitigated Negative Declaration Pursuant to the California Environmental Quality Act
NOTE: This building is a property bought by UC Health for $55 million to become a sports medicine facility. Source: https://labusinessjournal.com/real-estate/ucla-makes-55-million-buy-in-the-south-bay/.
F4 Action: 901 Levering Student Housing, Los Angeles Campus: Budget, Scope, External Financing, and Design Following Adoption of a Mitigated Negative Declaration Pursuant to the California Environmental Quality Act
--
1:30 pm Academic and Student Affairs Committee (open session)
Action: Approval of the Minutes of the Meeting of January 21, 2026
A1 Action: Approval of Multi-Year Plans for Professional Degree Supplemental Tuition (PDST) Increases for Four Graduate Professional Degree Programs
--
2:05 pm Compliance and Audit Committee (open session)
Action: Approval of the Minutes of the Meeting of November 20, 2025
C1 Action: Amendment of Internal Audit Charter
C2 Action: External Audit Plan for the Year Ending June 30, 2026
--
Upon end of open session:
Compliance and Audit Committee (closed session)
Action: Approval of the Minutes of the Meeting of January 20, 2026
C3(X) Action: Recommended Settlements for Board Action
Various medical cases proposed for settlement
C4(X) Discussion Appellate, Trial Court Developments and Updates
Various cases including CITY OF PASADENA, et al. v. REGENTS, et al. (Rose Bowl cases involving UCLA), DO NO HARM, et al. v. REGENTS, et al.; STUDENTS AGAINST RACIAL DISCRIMINATION v. REGENTS, et al.; ZHONG, et al. v. REGENTS, et al. (Reverse discrimination in admissions), DOES v. REGENTS, et al. (Heaps sexual abuse cases from UCLA), FEDERAL FUNDING LITIGATION (conflict with the federal govt.), PROTEST-RELATED CASES, and others.
C5(X) Discussion: Data and Trends in Professional Liability Settlements
C6(X) Information: Settlements and Separation Agreements under Delegated Authority Reported from December 1, 2025 to January 31, 2026
--
3:40 pm Board (closed session)
Action: Approval of the Minutes of the Meeting of January 21, 2026
Committee Reports Including Approval of Recommendations from Committees:
- Compliance and Audit Committee
- Finance and Capital Strategies Committee
- Governance Committee
- Health Services Committee
Officers’ and President’s Reports:
- Personnel Matters
- Report of Materials Mailed Between Meetings
==
Source: https://regents.universityofcalifornia.edu/meetings/agendas/march26.html.
No comments:
Post a Comment